Moderna confirms pre-outbreak hantavirus mRNA vaccine research with USAMRIID and Korea University

Bloomberg, Boston Globe and NBC News report (May 8, 2026) that Moderna had been conducting early-stage hantavirus mRNA vaccine research with the US Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Vaccine Innovation Center at Korea University College of Medicine well before the MV Hondius cluster emerged. Existing USAMRIID Phase 1 ANDV DNA vaccine trials have shown induction of neutralizing antibodies in humans. No licensed product exists yet; analysts say full development could take a decade absent an Operation Warp Speed-style federal push.

Cases

—

Deaths

—

Author

—

Disease

hantavirus